Global analysis of Lisinopril API
Source- Lifescience Intellipedia Team
The Global market size of this molecule by Volume 786 MT & by value 149 Mn USD & its growing by 6.1% and domestic Indian market 343MT and growing by 8.5%
Lisinopril is utilized to treat hypertension. Bringing down hypertension forestalls strokes, cardiovascular failures, and kidney issues.
It is also used to treat cardiovascular breakdown and further develop endurance after a heart attack. Lisinopril has a place with a class of medications known as ACE inhibitors.
It works by loosening up veins so blood can stream all the more without any problem.
Lisinopril (Prinivil, Zestril) is a generic drug that can be much less expensive than the brand name equivalent.
This API molecule is manufactured by 35 companies in which USDMF ( 21 holders) & EUGMP (22 holders) globally few players are Actavis Elizabeth Llc, Apotex Inc Etobicoke Site, Aurobindo Pharma Ltd, Lupin Ltd, Mylan Pharmaceuticals, are some of the companies.
Lisinopril production is centralized in China and India, although it is low in
the United States and Europe.
Because of the abundance of choices in the market, demand is concentrated in North
In the Global market of Lisinopril,
the total Numbers of Buyers are 100+ USADA ( 114 filled) & buying in
bulk quantity
For more analysis and depth insights of the above molecule or other molecules check the below link
https://www.chemxpert.in/api/buyer/Lisinopril
Lisinopril API is utilized to treat hypertension. Bringing down hypertension forestalls strokes, cardiovascular failures, and kidney issues.
It is also used to treat cardiovascular breakdown and further develop endurance after a heart attack. Lisinopril has a place with a class of medications known as ACE inhibitors.
It works by loosening up veins so blood can stream all the more without any problem.
Lisinopril (Prinivil, Zestril) is a generic drug that can be much less expensive than the brand name equivalent.
